Inhibition of adenosine A2A receptor (A2AR) by CPI-444 enhances CD8+T cell killing of a HER-2/neu expressing murine tumor

被引：2
|
作者：
Scott, Blake A.
Armstrong, Todd
Jaffee, Elizabeth M.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-320
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
320
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Fish Oil Enhances T Cell Function and Tumor Infiltration and Is Correlated With a Cancer Prevention Effect in HER-2/neu But Not PyMT Transgenic Mice
    Turbitt, William J.
    Black, Adam J.
    Collins, Shawntawnee D.
    Meng, Huicui
    Xu, Haifang
    Washington, Sharlene
    Aliaga, Cesar
    El-Bayoumy, Karam
    Manni, Andrea
    Rogers, Connie J.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2015, 67 (06): : 965 - 975
  • [32] Antibody association with HER-2/neu-targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
    Kim, Peter S.
    Armstrong, Todd D.
    Song, Hong
    Wolpoe, Matthew E.
    Weiss, Vivian
    Manning, Elizabeth A.
    Huang, Lan Qing
    Murata, Satoshi
    Sgouros, George
    Emens, Leisha A.
    Reilly, R. Todd
    Jaffee, Elizabeth M.
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (05): : 1700 - 1711
  • [33] Expansion and differentiation of vaccine induced high-affinity CD8+T cells to HER-2 requires distinct variants of the tumor antigen
    Kawano, K
    Efferson, CL
    Murray, JL
    Ioannides, CG
    FASEB JOURNAL, 2003, 17 (07): : C78 - C78
  • [34] Regulation of human T cell function by adenosine:: Evidence of a2a adenosine receptor inhibition of cytokine production by Cd4+ T cells and gastric T cells
    Alam, Mohammad S.
    Wiznerowicz, Elizabeth
    Wilson, Jeffrey
    Burnette, Brent
    Linden, Joel
    Figler, Robert
    Crowe, Sheila
    Ernst, Peter B.
    GASTROENTEROLOGY, 2007, 132 (04) : A397 - A397
  • [35] A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
    Seavey, Matthew M.
    Pan, Zhen-Kun
    Maciag, Paulo C.
    Wallecha, Anu
    Rivera, Sandra
    Paterson, Yvonne
    Shahabi, Vafa
    CLINICAL CANCER RESEARCH, 2009, 15 (03) : 924 - 932
  • [36] Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors
    Panagiota A. Sotiropoulou
    Sonia A. Perez
    Volfgang Voelter
    Hartmut Echner
    Ioannis Missitzis
    Nick B. Tsavaris
    Michael Papamichail
    Constantin N. Baxevanis
    Cancer Immunology, Immunotherapy, 2003, 52 : 771 - 779
  • [37] Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors
    Sotiropoulou, PA
    Perez, SA
    Voelter, V
    Echner, H
    Missitzis, I
    Tsavaris, NB
    Papamichail, M
    Baxevanis, CN
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (12) : 771 - 779
  • [38] Deletion of adenosine A2A receptors on CD8 T cells enhances their accumulation in tumors and tumor-draining lymph nodes, as well as their ability to control tumor outgrowth
    Vincent, Isaah S.
    Linden, Joel M.
    Engelhard, Victor H.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [39] Type 1 polarized HER-2/neu pulsed dendritic cell vaccines generate antitumor CD8+T cells despite the presence of antigen specific CD8 tolerance in patients with early non-invasive breast cancer
    Xu, Shuwen
    Koldovsky, Ursula
    Mick, Rosemarie
    Nisenbaum, Harvey
    Wang, Daniel
    Zhang, Paul
    Czerniecki, Brian J.
    CANCER RESEARCH, 2006, 66 (08)
  • [40] Non-immunodominant CD8+ T-cell responses can be harnessed to mount antitumor immunity in the tolerant HER-2/neu transgenic mice
    Uram, Jennifer
    Black, Chelsea
    Flynn, Emilee
    Huang, Lanqing
    Armstrong, Todd
    Jaffee, Elizabeth
    CANCER RESEARCH, 2009, 69
12345